logo

For the Inventor, By the Inventor

Sandy, UT, United States of America

Linxian Wu

This inventor holds 7 USPTO granted patents. Top assignee: Gull Laboratories, Inc.. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linxian Wu. Retrieved from https://idiyas.com/inventor/linxian-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 209(Granted Patents)


Company Filing History:

goldMedal7 out of 9 
 
Gull Laboratories, Inc.
 patents

Years Active: 1997-1999

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5861256 - Methods and apparatus for detection and discrimination of multiple (1999-01-19),
2. 5846783 - Methods and apparatus for preparing, amplifying, and discriminating (1998-12-08),
3. 5756701 - Specific oligonucleotide primer pairs and probes for discriminating (1998-05-26),
4. 5753444 - Methods and kits using inosine-containing probes for discriminating (1998-05-19),
5. 5738995 - Inosine-containing probes for detecting E.coli 0157:H7 (1998-04-14),
6. 5723294 - Methods for detection and discrimination of multiple analytes using (1998-03-03),
7. 5612473 - Methods, kits and solutions for preparing sample material for nucleic (1997-03-18),

Title: Linxian Wu: Innovator in Analyte Detection Technologies

Introduction

Linxian Wu is a prominent inventor based in Sandy, UT (US), known for his significant contributions to the field of analyte detection technologies. With a total of 7 patents to his name, Wu has developed innovative methods and apparatus that enhance the accuracy and efficiency of clinical laboratory testing.

Latest Patents

Wu's latest patents focus on advanced techniques for detecting and discriminating multiple analytes within test samples. One of his notable inventions provides methods and apparatus that allow for rapid, accurate, and convenient detection of multiple PCR-amplified target nucleic acid sequence hybrids within a single sample. This technology utilizes different fluorescent dyes to enable spectral distinction using data directly from fluorescence reader instruments. Another significant patent outlines methods for preparing, amplifying, and discriminating nucleic acid sequences in a user-friendly and cost-effective manner. This invention emphasizes a streamlined process that can complete sample preparation, amplification, and differentiation in about five hours or less.

Career Highlights

Linxian Wu is currently associated with Gull Laboratories, Inc., where he continues to push the boundaries of innovation in the field of clinical diagnostics. His work has been instrumental in developing technologies that improve the speed and reliability of laboratory testing.

Collaborations

Wu has collaborated with notable colleagues, including Jana Coombs and Sharon L Malmstrom, contributing to a dynamic research environment that fosters innovation and advancement in analyte detection.

Conclusion

Linxian Wu's contributions to the field of analyte detection are marked by his innovative patents and collaborative efforts. His work continues to impact clinical laboratory practices, making testing more efficient and accessible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…